Cargando…
Status of radiotherapy in a multidisciplinary cancer board
Multidisciplinary cancer boards (CBs) for making cancer treatment decisions have become popular in many countries; however, the status of radiotherapy in CBs and the influence of CBs on radiotherapy decisions have not been studied. To clarify these issues, we reviewed the minutes of our CBs from Feb...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951068/ https://www.ncbi.nlm.nih.gov/pubmed/23979074 http://dx.doi.org/10.1093/jrr/rrt104 |
_version_ | 1782307084982812672 |
---|---|
author | Ichikawa, Mayumi Nemoto, Kenji Miwa, Misako Ohta, Ibuki Nomiya, Takuma Yamakawa, Mayumi Itho, Yuriko Fukui, Tadahisa Yoshioka, Takashi |
author_facet | Ichikawa, Mayumi Nemoto, Kenji Miwa, Misako Ohta, Ibuki Nomiya, Takuma Yamakawa, Mayumi Itho, Yuriko Fukui, Tadahisa Yoshioka, Takashi |
author_sort | Ichikawa, Mayumi |
collection | PubMed |
description | Multidisciplinary cancer boards (CBs) for making cancer treatment decisions have become popular in many countries; however, the status of radiotherapy in CBs and the influence of CBs on radiotherapy decisions have not been studied. To clarify these issues, we reviewed the minutes of our CBs from February 2010 to March 2012, and we classified planned treatments discussed at the CBs into five categories and analyzed decisions concerning radiotherapy in each category. The fraction of cases for which radiotherapy was recommended was 536/757 (71%). These cases included 478 cases (63%) for which radiation therapy was planned and four cases (0.5%) for which radiation therapy was unexpectedly recommended. On the other hand, radiation therapy was canceled in 21 cases (4%) for which radiation therapy had been planned. This study showed that radiotherapy was discussed in many cases at CBs and that CBs have a great influence on decisions concerning radiotherapy. |
format | Online Article Text |
id | pubmed-3951068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-39510682014-03-12 Status of radiotherapy in a multidisciplinary cancer board Ichikawa, Mayumi Nemoto, Kenji Miwa, Misako Ohta, Ibuki Nomiya, Takuma Yamakawa, Mayumi Itho, Yuriko Fukui, Tadahisa Yoshioka, Takashi J Radiat Res Oncology Multidisciplinary cancer boards (CBs) for making cancer treatment decisions have become popular in many countries; however, the status of radiotherapy in CBs and the influence of CBs on radiotherapy decisions have not been studied. To clarify these issues, we reviewed the minutes of our CBs from February 2010 to March 2012, and we classified planned treatments discussed at the CBs into five categories and analyzed decisions concerning radiotherapy in each category. The fraction of cases for which radiotherapy was recommended was 536/757 (71%). These cases included 478 cases (63%) for which radiation therapy was planned and four cases (0.5%) for which radiation therapy was unexpectedly recommended. On the other hand, radiation therapy was canceled in 21 cases (4%) for which radiation therapy had been planned. This study showed that radiotherapy was discussed in many cases at CBs and that CBs have a great influence on decisions concerning radiotherapy. Oxford University Press 2014-03 2013-08-26 /pmc/articles/PMC3951068/ /pubmed/23979074 http://dx.doi.org/10.1093/jrr/rrt104 Text en © The Author 2013. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Oncology Ichikawa, Mayumi Nemoto, Kenji Miwa, Misako Ohta, Ibuki Nomiya, Takuma Yamakawa, Mayumi Itho, Yuriko Fukui, Tadahisa Yoshioka, Takashi Status of radiotherapy in a multidisciplinary cancer board |
title | Status of radiotherapy in a multidisciplinary cancer board |
title_full | Status of radiotherapy in a multidisciplinary cancer board |
title_fullStr | Status of radiotherapy in a multidisciplinary cancer board |
title_full_unstemmed | Status of radiotherapy in a multidisciplinary cancer board |
title_short | Status of radiotherapy in a multidisciplinary cancer board |
title_sort | status of radiotherapy in a multidisciplinary cancer board |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951068/ https://www.ncbi.nlm.nih.gov/pubmed/23979074 http://dx.doi.org/10.1093/jrr/rrt104 |
work_keys_str_mv | AT ichikawamayumi statusofradiotherapyinamultidisciplinarycancerboard AT nemotokenji statusofradiotherapyinamultidisciplinarycancerboard AT miwamisako statusofradiotherapyinamultidisciplinarycancerboard AT ohtaibuki statusofradiotherapyinamultidisciplinarycancerboard AT nomiyatakuma statusofradiotherapyinamultidisciplinarycancerboard AT yamakawamayumi statusofradiotherapyinamultidisciplinarycancerboard AT ithoyuriko statusofradiotherapyinamultidisciplinarycancerboard AT fukuitadahisa statusofradiotherapyinamultidisciplinarycancerboard AT yoshiokatakashi statusofradiotherapyinamultidisciplinarycancerboard |